Related references
Note: Only part of the references are listed.Quantification of thymosin β4 in human cerebrospinal fluid using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry
Elena Urso et al.
ANALYTICAL BIOCHEMISTRY (2010)
An update on clinical proteomics in Alzheimer's research
Minna A. Korolainen et al.
JOURNAL OF NEUROCHEMISTRY (2010)
Multiple sclerosis: Identification and clinical evaluation of novel CSF biomarkers
Jan Ottervald et al.
JOURNAL OF PROTEOMICS (2010)
Ubiquitin as potential cerebrospinal fluid marker of Creutzfeldt-Jakob disease
Petra Steinacker et al.
PROTEOMICS (2010)
The role of proteomics in dementia and Alzheimer's disease
Maria Zellner et al.
ACTA NEUROPATHOLOGICA (2009)
Development of affinity columns for the removal of high-abundance proteins in cerebrospinal fluid
Margareta Ramström et al.
BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY (2009)
Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease
I. Zerr et al.
BRAIN (2009)
Cells and prions: A license to replicate
Mario Nuvolone et al.
FEBS LETTERS (2009)
Curative properties of antibodies against prion protein: A comparative in vitro study of monovalent fragments and divalent antibodies
Coralie Alexandrenne et al.
JOURNAL OF NEUROIMMUNOLOGY (2009)
The Nigrostriatal Pathway in Creutzfeldt-Jakob Disease
Anne Vital et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2009)
Prion Disease Diagnosis by Proteomic Profiling
Allen Herbst et al.
JOURNAL OF PROTEOME RESEARCH (2009)
Statistical Design of Quantitative Mass Spectrometry-Based Proteomic Experiments
Ann L. Oberg et al.
JOURNAL OF PROTEOME RESEARCH (2009)
Proteomics in human Parkinson's disease research
Virginie Licker et al.
JOURNAL OF PROTEOMICS (2009)
Movement Disturbances in the Differential Diagnosis of Creutzfeldt-Jakob Disease
Jan Edler et al.
MOVEMENT DISORDERS (2009)
ALZHEIMER'S DISEASE A prion protein connection
Moustapha Cisse et al.
NATURE (2009)
CELL BIOLOGY Beyond the prion principle
Adriano Aguzzi
NATURE (2009)
Cellular prion protein mediates impairment of synaptic plasticity by amyloid-β oligomers
Juha Lauren et al.
NATURE (2009)
14-3-3 CSF levels in sporadic Creutzfeldt-Jakob disease differ across molecular subtypes
K. Gmitterova et al.
NEUROBIOLOGY OF AGING (2009)
Continuous intraventricular infusion of pentosan polysulfate: Clinical trial against prion diseases
Yoshio Tsuboi et al.
NEUROPATHOLOGY (2009)
De novo generation of a transmissible spongiform encephalopathy by mouse transgenesis
Christina J. Sigurdson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Thymosin β4 is differentially expressed in the cerebrospinal fluid of Creutzfeldt-Jakob disease patients: a MALDI-TOF MS protein profiling study
Antonio Qualtieri et al.
PROTEOMICS CLINICAL APPLICATIONS (2009)
Prion diseases: From protein to cell pathology
Gabor G. Kovacs et al.
AMERICAN JOURNAL OF PATHOLOGY (2008)
Comprehensive transcriptional profiling of prion infection in mouse models reveals networks of responsive genes
Garrett Sorensen et al.
BMC GENOMICS (2008)
Integrated analysis of the cerebrospinal fluid peptidome and proteome
Alexandre Zougman et al.
JOURNAL OF PROTEOME RESEARCH (2008)
Cerebrospinal fluid-optimized two-dimensional difference gel electrophoresis (2-D DIGE) facilitates the differential diagnosis of Creutzfeldt-Jakob disease
Peter Brechlin et al.
PROTEOMICS (2008)
Membrane and membrane-associated proteins involved in the aggressive phenotype displayed by highly invasive cancer cells
Paul Dowling et al.
PROTEOMICS (2008)
Clinical proteomics of the cerebrospinal fluid: Towards the discovery off now biomarkers
Stephane Roche et al.
PROTEOMICS CLINICAL APPLICATIONS (2008)
Endogeneous peptide profiling of cerebrospinal fluid by MALDI-TOF mass spectrometry: Optimization of magnetic bead-based peptide capture and analysis of preanalytical variables
Connie R. Jimenez et al.
PROTEOMICS CLINICAL APPLICATIONS (2007)
Cerebrospinal fluid proteome profile in multiple sclerosis
V. Lehmensiek et al.
MULTIPLE SCLEROSIS (2007)
Mass spectrometric detection of attomole amounts of the prion protein by nanoLC/MS/MS
Bruce Onisko et al.
JOURNAL OF THE AMERICAN SOCIETY FOR MASS SPECTROMETRY (2007)
The spread of prions through the body in naturally acquired transmissible spongiform encephalopathies
Michael Beekes et al.
FEBS JOURNAL (2007)
Clinical proteomics: A need to define the field and to begin to set adequate standards
Harald Mischak et al.
PROTEOMICS CLINICAL APPLICATIONS (2007)
Cerebrospinal fluid proteomic biomarkers for Alzheimer's disease
Erin J. Finehout et al.
ANNALS OF NEUROLOGY (2007)
Proteomic analysis of the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease
Lukas Cepek et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2007)
Proteomic analysis of cerebrospinal fluid discriminates malignant and nonmalignant disease of the central nervous system and identifies specific protein markers
Fatima W. Khwaja et al.
PROTEOMICS (2006)
Brain-derived proteins in the CSF, do they correlate with brain pathology in CJD?
Constanze Boesenberg-Grosse et al.
BMC NEUROLOGY (2006)
Determinants of diagnostic investigation sensitivities across the clinical spectrum of sporadic Creutzfeldt-Jakob disease
S. J. Collins et al.
BRAIN (2006)
Clinical findings and diagnostic tests in the MV2 subtype of sporadic CJD
Anna Krasnianski et al.
BRAIN (2006)
CSF tests in the differential diagnosis of Creutzfeldt-Jakob disease
P. Sanchez-Juan et al.
NEUROLOGY (2006)
Iatrogenic Creutzfeldt-Jakob disease - The waning of an era
Paul Brown et al.
NEUROLOGY (2006)
Comparative proteomics in neurodegenerative and non-neurodegenerative diseases suggest nodal point proteins in regulatory networking
Claus Zabel et al.
JOURNAL OF PROTEOME RESEARCH (2006)
Protein biomarker discovery and validation: the long and uncertain path to clinical utility
Nader Rifai et al.
NATURE BIOTECHNOLOGY (2006)
Molecular morphology and toxicity of cytoplasmic prion protein aggregates in neuronal and non-neuronal cells
Catherine Grenier et al.
JOURNAL OF NEUROCHEMISTRY (2006)
The interaction between cytoplasmic prion protein and the hydrophobic lipid core of membrane correlates with neurotoxicity
XH Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
EEG in Creutzfeldt-Jakob disease
Heinz Gregor Wieser et al.
CLINICAL NEUROPHYSIOLOGY (2006)
Determination of β-amyloid peptide signatures in cerebrospinal fluid using immunoprecipitation-mass spectrometry
E Portelius et al.
JOURNAL OF PROTEOME RESEARCH (2006)
Searching for markers of Creutzfeldt-Jakob disease in cerebrospinal fluid by two-dimensional mapping
Chiara Piubelli et al.
PROTEOMICS (2006)
Prions and their lethal journey to the brain
NA Mabbott et al.
NATURE REVIEWS MICROBIOLOGY (2006)
Proteomics of the heart - Unraveling disease
E McGregor et al.
CIRCULATION RESEARCH (2006)
Chronic wasting disease of elk and deer and Creutzfeldt-Jakob disease - Comparative analysis of the scrapie prion protein
ZL Xie et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Identification of CSF biomarkers for frontotemporal dementia using SELDI-TOF
U Rüetschi et al.
EXPERIMENTAL NEUROLOGY (2005)
Sporadic Creutzfeldt-Jakob disease -: Clinical and diagnostic characteristics of the rare VV1 type
B Meissner et al.
NEUROLOGY (2005)
Prefractionation of cerebrospinal fluid to enhance glycoprotein concentration prior to structural determination with FT-ICR mass spectrometry
C Sihlbom et al.
JOURNAL OF PROTEOME RESEARCH (2005)
Proteomic patterns and prediction of glomerulosclerosis and its mechanisms
BJ Xu et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
Truncated cystatin C in cerebrospiral fluid: Technical artefact or biological process?
O Carrette et al.
PROTEOMICS (2005)
Anchorless prion protein results in infectious amyloid disease without clinical scrapie
B Chesebro et al.
SCIENCE (2005)
Evaluation of protein depletion methods for the analysis of total-, phospho- and glycoproteins in lumbar cerebrospinal fluid
Y Ogata et al.
JOURNAL OF PROTEOME RESEARCH (2005)
In vitro generation of infectious scrapie prions
J Castilla et al.
CELL (2005)
Cytosolic prion protein (PrP) is not toxic in N2a cells and primary neurons expressing pathogenic PrP mutations
L Fioriti et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Human cerebrospinal fluid peptidomics
XL Yuan et al.
JOURNAL OF MASS SPECTROMETRY (2005)
Proteomics analysis of prefractionated human lumbar cerebrospinal fluid
XL Yuan et al.
PROTEOMICS (2005)
Top-down identification of endogenous peptides up to 9 kDa in cerebrospinal fluid and brain tissue by nanoelectrospray quadrupole time-of-flight tandem mass spectrometry
T Möhring et al.
JOURNAL OF MASS SPECTROMETRY (2005)
Prions, cytokines, and chemokines: A meeting in lymphoid organs
A Aguzzi et al.
IMMUNITY (2005)
The impact of blood contamination on the proteome of cerebrospinal fluid
JS You et al.
PROTEOMICS (2005)
MALDI-TOF mass spectrometry analysis of cerebrospinal fluid tryptic peptide profiles to diagnose leptomeningeal metastases in patients with breast cancer
LJ Dekker et al.
MOLECULAR & CELLULAR PROTEOMICS (2005)
Differential diagnosis of 201 possible Creutzfeldt-Jakob disease patients
B Van Everbroeck et al.
JOURNAL OF NEUROLOGY (2004)
Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion
CA Llewelyn et al.
LANCET (2004)
Cystatin C as a potential cerebrospinal fluid marker for the diagnosis of Creutzfeldt-Jakob disease
JC Sanchez et al.
PROTEOMICS (2004)
Towards two-dimensional electrophoresis mapping of the cerebrospinal fluid proteome from a single individual
EJ Finehout et al.
ELECTROPHORESIS (2004)
Proteomic analysis of multiple sclerosis cerebrospinal fluid
BN Hammack et al.
MULTIPLE SCLEROSIS (2004)
Identification of up-regulated genes by array analysis in scrapie-infected mouse brains
AR Brown et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2004)
Identification of differentially expressed genes in scrapie-infected mouse brains by using global gene expression technology
W Xiang et al.
JOURNAL OF VIROLOGY (2004)
CSF lactate dehydrogenase activity in patients with Creutzfeldt-Jakob disease exceeds that in other dementias
H Schmidt et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2004)
Extraneural pathologic prion protein in sporadic Creutzfeldt-Jakob disease
M Glatzel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Depleting neuronal PrP in prion infection prevents disease and reverses spongiosis
G Mallucci et al.
SCIENCE (2003)
Cytosolic prion protein is not toxic and protects against Bax-mediated cell death in human primary neurons
X Roucou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
The sympathetic nervous system is involved in variant Creutzfeldt-Jakob disease
S Haïk et al.
NATURE MEDICINE (2003)
A panel of cerebrospinal fluid potential biomarkers for the diagnosis of Alzheimer's disease
O Carrette et al.
PROTEOMICS (2003)
A potential cerebrospinal fluid and plasmatic marker for the diagnosis of Creutzfeldt-Jakob disease
E Guillaume et al.
PROTEOMICS (2003)
Molecular classification of sporadic Creutzfeldt-Jakob disease
AF Hill et al.
BRAIN (2003)
Challenging the clinical utility of the 14-3-3 protein for the diagnosis of sporadic Creutzfeldt-Jakob disease
MD Geschwind et al.
ARCHIVES OF NEUROLOGY (2003)
Unique inflammatory RNA profiles of microglia in Creutzfeldt-Jakob disease
CA Baker et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Studies of the pathophysiological mechanisms in frontotemporal dementia by proteome analysis of CSF proteins
P Davidsson et al.
MOLECULAR BRAIN RESEARCH (2002)
Neurotoxicity and neurodegeneration when PrP accumulates in the cytosol
JY Ma et al.
SCIENCE (2002)
Mutations of the prion protein gene -: Phenotypic spectrum
GG Kovács et al.
JOURNAL OF NEUROLOGY (2002)
Use of 14-3-3 in the diagnosis of Creutzfeldt-Jakob disease
AJE Green
BIOCHEMICAL SOCIETY TRANSACTIONS (2002)
Tau protein and 14-3-3 protein in the differential diagnosis of Creutzfeldt-Jakob disease
M Otto et al.
NEUROLOGY (2002)
Validation of a luminescence immunoassay for the detection of PrPSc in brain homogenate
K Biffiger et al.
JOURNAL OF VIROLOGICAL METHODS (2002)
Doppel-induced cerebellar degeneration in transgenic mice
RC Moore et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Detection of variant Creutzfeld-Jakob disease infectivity in extraneural tissues
ME Bruce et al.
LANCET (2001)
Tissue distribution of protease resistant prion protein in variant Creutzfeldt-Jakob disease using a highly sensitive immunoblotting assay
JDF Wadsworth et al.
LANCET (2001)
Temporary depletion of complement component C3 or genetic deficiency of C1q significantly delays onset of scrapie
NA Mabbott et al.
NATURE MEDICINE (2001)
Complement facilitates early prion pathogenesis
MA Klein et al.
NATURE MEDICINE (2001)
The expression and potential function of cellular prion protein in human lymphocytes
RL Li et al.
CELLULAR IMMUNOLOGY (2001)
Blood infectivity and the prospects for a diagnostic screening test in Creutzfeldt-Jakob disease
P Brown et al.
JOURNAL OF LABORATORY AND CLINICAL MEDICINE (2001)
Elevation of neuron-specific enolase in serum and cerebrospinal fluid of early stage Creutzfeldt-Jakob disease
I Kohira et al.
ACTA NEUROLOGICA SCANDINAVICA (2000)
Iatrogenic Creutzfeldt-Jakob disease at the millennium
P Brown et al.
NEUROLOGY (2000)
Effect of the E200K mutation on prion protein metabolism - Comparative study of a cell model and human brain
S Capellari et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
NMR structure of the bovine prion protein
FL Garcia et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Differential constitutive and activation-dependent expression of prion protein in human peripheral blood leucocytes
J Dürig et al.
BRITISH JOURNAL OF HAEMATOLOGY (2000)
Monitoring plasma processing steps with a sensitive Western blot assay for the detection of the prion protein
DC Lee et al.
JOURNAL OF VIROLOGICAL METHODS (2000)
Share Paper
